Immedica
Immedica at a glance
Immedica is a leading European specialty pharma commercialisation and distribution platform focused on orphan and highly niched indications with high unmet medical needs.
Immedica serves patients in more than 50 countries, with capabilities covering marketing and sales, compliance, pharmacovigilance, quality assurance, regulatory and medical affairs as well as market access.
Immedica facts
Pharmaceuticals
May 2018
Stockholm, Sweden
Anders Edvell (CEO)
Simon Falk (CFO)
Magnus Edlund
Fredrik Odin
Edvard Hubendick
180
Investment thesis
- Launch and commercialisation of rare disease drugs in the EU and ME is a highly attractive and sustainable business
- Potential to expand into a leading pan-European position in a market with high barriers to entry
- Clear opportunity to multiply size by pursuing an active business development agenda, spanning distribution, in-licensing deals and acquisitions
UN SDG Goals
Other portfolio companies
Oticon Medical
Oticon Medical is a global hearing healthcare company specializing in bone-anchored hearing solutions (BAHS), a niche segment addressing conductive hearing loss.
Qufora
Qufora is a fast-growing Danish medical technology product company with focus on transanal irrigation (“TAI”) products and collecting devices
Avia Pharma
Avia is a leading North European OTC/Rx platform